Cargando…
Pharmacological perspective: glycyrrhizin may be an efficacious therapeutic agent for COVID-19
Coronavirus disease 2019 (COVID-19) caused by the previously unknown pathogen, severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) is now a global pandemic. There are no vaccines or specific treatments against this new virus; therefore, there is an urgent need to advance novel thera...
Autores principales: | Luo, Pan, Liu, Dong, Li, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V. and International Society of Chemotherapy.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180159/ https://www.ncbi.nlm.nih.gov/pubmed/32335281 http://dx.doi.org/10.1016/j.ijantimicag.2020.105995 |
Ejemplares similares
-
Glycyrrhizin for treatment of CRS caused by CAR T-cell therapy: A pharmacological perspective
por: Qi, Xingxing, et al.
Publicado: (2023) -
The Pharmacological Activities of Glycyrrhizinic Acid (“Glycyrrhizin”) and Glycyrrhetinic Acid
por: Graebin, Cedric Stephan
Publicado: (2017) -
Glycyrrhizin as antiviral agent against Hepatitis C Virus
por: Ashfaq, Usman A, et al.
Publicado: (2011) -
Therapeutic effects of mesoderm introduction of compound glycyrrhizin injection on the treatment of rosacea
por: Li, Shanshan, et al.
Publicado: (2023) -
Symptomatic Protective Action of Glycyrrhizin (Licorice) in COVID-19 Infection?
por: Murck, Harald
Publicado: (2020)